RECENT NEWS

South West London Pathology (SWLP) has introduced cutting-edge technologies to its laboratories to create one of the most modern, innovative, and efficient clinical blood science services in the country.

In medical settings, biofilms make infections harder to treat when they form protective shields for bacteria on devices like catheters and implants. UC Riverside scientists have now discovered a chemical that plants produce when they're stressed prevents biofilm from forming. The breakthrough offers potential advances in healthcare as well as preventing equipment corrosion in industrial settings.

A ground-breaking UK study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in hospitals.

Biohit HealthCare is pleased to announce that a clinical study conducted by Homerton University Hospital NHS Foundation Trust, London, has confirmed the diagnostic accuracy of GastroPanel in identifying gastric cancer risk in patients with upper abdominal complaints.

NHS staff experienced the busiest year on record for A&E and ambulance services last year, new figures show, as flu continues to pile pressure on hospitals into 2025.

A new agreement has been struck with the independent sector as part of plans to end the hospital waiting list backlog set out by the Prime Minister.

Emergency Departments in Scotland are struggling against the combined pressures of extreme weather and a rise in hospital admissions from flu. The Royal College of Emergency Medicine (RCEM) has described the country’s health service as being “in the depth of a winter crisis” as Scotland braces itself against snow and ice.

A new Urology Outpatients Department is being constructed at the Royal Berkshire Hospital in Reading by MTX Contracts, which employs modern methods of construction to deliver projects faster, safer, greener and more cost effectively than conventional building methods.

Kearney Urology Centre has reported a 50% reduction in biopsies since adopting EpiSwitch PSE, a new accurate blood test for prostate cancer.

Sheffield Children’s NHS Foundation Trust has successfully gone live with its Electronic Prescribing and Medicines Administration (EPMA) system provided by System C in the Paediatric Critical Care Unit (PCCU).

For the first time, NICE has recommended an innovative new treatment to help stop babies, children and young people who are undergoing cancer treatment from losing their hearing.

Mölnlycke Health Care, a world-leading MedTech company specialising in wound care solutions, announced an investment of USD 8 million in Siren. The healthcare tech company Siren is on a mission to help reduce the risk of diabetic foot ulcers by early detection of potential injuries through temperature-sensing textile technology.

The 5th Annual Operating Theatres show is coming to London on the 11th March 2025 and will tackle some of the biggest challenges facing surgical teams - from the elective surgery backlog, to sustainability.

​The proportion of patients being diagnosed with cancer at an early stage in England has risen to its highest ever level, according to new NHS analysis.

A 'revolutionised' NHS App is among a raft of proposals aimed at giving patients greater power over how and when they receive elective treatment.

As part of a Managed Equipment Service (MES) contract and in collaboration with North Cumbria Integrated Care Trust (NCIC), Ergéa has supported the development of a state-of-the-art endoscopy unit at Cumberland Infirmary in Carlisle.

​In a new paper, published in Nature Reviews Gastroenterology & Hepatology, eight scientists have examined the evidence on using probiotics to restore the gut bacterial community during and after antibiotic treatment.

Giving inexperienced clinicians “just-in-time” training with an expert just before they carry out a procedure boosts their success rate and could improve patient safety, finds a study in The BMJ.

Government advisers and university leaders recently joined the launch of a major new research hub, led by UCL and the University of Cambridge, that aims to harness quantum technology to improve early diagnosis and treatment of disease.

Research published in the Neuron journal could help neurologists prescribe personalised treatment to people living with multiple sclerosis (MS), in the future, after scientists studied more than half a million brain cells.